Tandem Diabetes Care (TNDM) Accumulated Expenses (2013 - 2026)

Tandem Diabetes Care's Accumulated Expenses history runs 14 years deep, the most recent figure standing at $19.2 million for Q1 2026.

• Quarterly Accumulated Expenses fell 61.86% year-over-year to $19.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.2 million (down 61.86% YoY) and the FY2025 annual result came in at $21.0 million, down 67.23% from the prior year.
• Accumulated Expenses was $19.2 million for Q1 2026 at Tandem Diabetes Care, down from $21.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $64.1 million in Q4 2024 and bottomed at $7.9 million in Q3 2022.
• A 5-year average of $26.0 million and a median of $19.2 million in 2026 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses plunged 83.27% — and 2025, when it jumped 361.46%.
• Tandem Diabetes Care's Accumulated Expenses stood at $9.6 million in 2022, then surged by 352.63% to $43.4 million in 2023, then surged by 47.66% to $64.1 million in 2024, then slumped by 67.23% to $21.0 million in 2025, then decreased by 8.44% to $19.2 million in 2026.
• Business Quant data shows TNDM's Accumulated Expenses at $19.2 million in Q1 2026, $21.0 million in Q4 2025, and $12.5 million in Q3 2025.